Effects of Vitamin D Supplementation on Prevention of Type 2 Diabetes in Patients With Prediabetes: A Systematic Review and Meta-analysis
Top Cited Papers
- 11 June 2020
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 43 (7), 1650-1658
- https://doi.org/10.2337/dc19-1708
Abstract
BACKGROUND While observational studies have shown an association between vitamin D insufficiency and diabetes, it is unclear whether intervention with vitamin D supplements can lower the risk of type 2 diabetes mellitus (T2DM). PURPOSE To assess whether vitamin D supplementation reduces the risk of T2DM in people with prediabetes. DATA SOURCES We searched MEDLINE, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL) from inception to 5 July 2019. STUDY SELECTION We included randomized controlled trials assessing vitamin D supplementation versus placebo in relation to new-onset T2DM in people with prediabetes. DATA EXTRACTION We screened studies and extracted data from published trials independently. DATA SYNTHESIS We identified eight eligible trials with a total of 4,896 subjects. Vitamin D supplementation significantly reduced the risk of T2DM (risk ratio [RR] 0.89 [95% CI 0.80–0.99]; I2 = 0%). Benefit was found in nonobese subjects (RR 0.73 [95% CI 0.57–0.92]) but not in obese subjects (RR 0.95 [95% CI 0.84–1.08]) (Pinteraction = 0.048). The reversion of prediabetes to normoglycemia occurred in 116 of 548 (21.2%) participants in the vitamin D group and 75 of 532 (14.1%) in the control group. Vitamin D supplementation increased reversion rate of prediabetes to normoglycemia (RR 1.48 [95% CI 1.14–1.92]; I2 = 0%.) LIMITATIONS Definitions of prediabetes and new-onset diabetes in eligible studies were different, and long-term data on outcomes of T2DM prevention were lacking. CONCLUSIONS In persons with prediabetes, vitamin D supplementation reduces the risk of T2DM and increases the reversion rate of prediabetes to normoglycemia. The benefit of the prevention of T2DM could be limited to nonobese subjects. Individual participant data meta-analyses are needed to confirm these findings.This publication has 50 references indexed in Scilit:
- High-Dose Vitamin D Supplementation in People With Prediabetes and Hypovitaminosis DDiabetes Care, 2013
- Does the intramuscular injection of vitamin D increase insulin resistance?Journal of Research in Pharmacy Practice, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Association of Vitamin D With Insulin Resistance and β-Cell Dysfunction in Subjects at Risk for Type 2 DiabetesDiabetes Care, 2010
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationPLoS Medicine, 2009
- Mechanism of Vitamin D Receptor Inhibition of Cholesterol 7α-Hydroxylase Gene Transcription in Human HepatocytesPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2008
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-AnalysisJournal of Clinical Endocrinology & Metabolism, 2007
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Vitamin D Receptor Gene Expression Is Up-Regulated by 1, 25-Dihydroxyvitamin D3 in 3T3-L1 PreadipocytesBiochemical and Biophysical Research Communications, 1993